explore -WSS

explore

author：leisure time 2025-09-06 05:22:40 - browse：7581

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： 3 questions for the future of Biden's cancer moonshot

WSS

Stroke deaths set to near 10 million globally by 2050

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

FDA panel signals lack of confidence in Amgen cancer drug data

Congenital heart disease patients face new threat of heart failure

AI can decode, harness the power of the humane immune system

After sickle

Wikipedia

explore

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Colorectal cancer study finds potential in overlooked immune cell

Medical leaders decry Supreme Court decision on affirmative action

AI can decode, harness the power of the humane immune system

Drug repurposing or repositioning? The language matters

The woman behind the Dana Farber

In Memoriam: Notable people who died in 2023

Why age limits for politicians are a terrible idea

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

knowledge

Stroke deaths set to near 10 million globally by 2050

Congenital heart disease patients face new threat of heart failure

Teach medical students about patients with intellectual disabilities

Analysis of telehealth claims data suggest service duplication

The woman behind the Dana Farber

Leukemia patients are helped by Syndax's new type of therapy

hotspot

focus

hotspot

focus